BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33558678)

  • 1. Effects of topiramate on neural responses to alcohol cues in treatment-seeking individuals with alcohol use disorder: preliminary findings from a randomized, placebo-controlled trial.
    Wetherill RR; Spilka N; Jagannathan K; Morris P; Romer D; Pond T; Lynch KG; Franklin TR; Kranzler HR
    Neuropsychopharmacology; 2021 Jul; 46(8):1414-1420. PubMed ID: 33558678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baclofen attenuates fMRI alcohol cue reactivity in treatment-seeking alcohol dependent individuals.
    Logge WB; Morris RW; Baillie AJ; Haber PS; Morley KC
    Psychopharmacology (Berl); 2021 May; 238(5):1291-1302. PubMed ID: 30788529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder.
    Karl D; Bumb JM; Bach P; Dinter C; Koopmann A; Hermann D; Mann K; Kiefer F; Vollstädt-Klein S
    Psychopharmacology (Berl); 2021 Aug; 238(8):2179-2189. PubMed ID: 33846866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial.
    Grodin EN; Bujarski S; Towns B; Burnette E; Nieto S; Lim A; Lin J; Miotto K; Gillis A; Irwin MR; Evans C; Ray LA
    Transl Psychiatry; 2021 Jun; 11(1):355. PubMed ID: 34120149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain Catastrophizing Is Associated With Increased Alcohol Cue-Elicited Neural Activity Among Individuals With Alcohol Use Disorder.
    Nieto SJ; Grodin EN; Burnette EM; Cahill CM; Ray LA
    Alcohol Alcohol; 2022 Nov; 57(6):727-733. PubMed ID: 35788255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessments.
    Miranda R; MacKillop J; Treloar H; Blanchard A; Tidey JW; Swift RM; Chun T; Rohsenow DJ; Monti PM
    Addict Biol; 2016 Jan; 21(1):171-82. PubMed ID: 25353306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
    Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
    Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-dose baclofen on cue reactivity in alcohol dependence: A randomized, placebo-controlled pharmaco-fMRI study.
    Beck A; Pelz P; Lorenz RC; Charlet K; Geisel O; Heinz A; Wüstenberg T; Müller CA
    Eur Neuropsychopharmacol; 2018 Nov; 28(11):1206-1216. PubMed ID: 30217552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers.
    Grodin EN; Burnette EM; Green R; Lim AC; Miotto K; Ray LA
    Drug Alcohol Depend; 2021 Aug; 225():108825. PubMed ID: 34175784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder.
    Robinson JD; Cui Y; Karam-Hage M; Kypriotakis G; Versace F; Ait-Daoud Tiouririne N; Anthenelli RM; Cinciripini PM
    Alcohol Clin Exp Res; 2022 Mar; 46(3):384-395. PubMed ID: 35037278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of varenicline on smoking cue–triggered neural and craving responses.
    Franklin T; Wang Z; Suh JJ; Hazan R; Cruz J; Li Y; Goldman M; Detre JA; O'Brien CP; Childress AR
    Arch Gen Psychiatry; 2011 May; 68(5):516-26. PubMed ID: 21199958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
    Schacht JP; Randall PK; Latham PK; Voronin KE; Book SW; Myrick H; Anton RF
    Neuropsychopharmacology; 2017 Dec; 42(13):2640-2653. PubMed ID: 28409564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of brain functional connectivity to assess cognitive control over cue-processing in Alcohol Use Disorder.
    Strosche A; Zhang X; Kirsch M; Hermann D; Ende G; Kiefer F; Vollstädt-Klein S
    Addict Biol; 2021 Jan; 26(1):e12863. PubMed ID: 31908107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of D-cycloserine on extinction of mesolimbic cue reactivity in alcoholism: a randomized placebo-controlled trial.
    Kiefer F; Kirsch M; Bach P; Hoffmann S; Reinhard I; Jorde A; von der Goltz C; Spanagel R; Mann K; Loeber S; Vollstädt-Klein S
    Psychopharmacology (Berl); 2015 Jul; 232(13):2353-62. PubMed ID: 25697860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study.
    Miranda R; MacKillop J; Monti PM; Rohsenow DJ; Tidey J; Gwaltney C; Swift R; Ray L; McGeary J
    Alcohol Clin Exp Res; 2008 Mar; 32(3):489-97. PubMed ID: 18215213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent heavy drinkers' amplified brain responses to alcohol cues decrease over one month of abstinence.
    Brumback T; Squeglia LM; Jacobus J; Pulido C; Tapert SF; Brown SA
    Addict Behav; 2015 Jul; 46():45-52. PubMed ID: 25796007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized pilot trial of topiramate for alcohol use disorder in veterans with traumatic brain injury: Effects on alcohol use, cognition, and post-concussive symptoms.
    Pennington DL; Bielenberg J; Lasher B; Herbst E; Abrams G; Novakovic-Agopian T; Batki SL
    Drug Alcohol Depend; 2020 Sep; 214():108149. PubMed ID: 32712569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-Induced Sensitization of Insula Activation Predicts Alcohol Craving and Alcohol Use in Alcohol Use Disorder.
    Bach P; Zaiser J; Zimmermann S; Gessner T; Hoffmann S; Gerhardt S; Berhe O; Bekier NK; Abel M; Radler P; Langejürgen J; Tost H; Lenz B; Vollstädt-Klein S; Stallkamp J; Kirschbaum C; Kiefer F
    Biol Psychiatry; 2024 Feb; 95(3):245-255. PubMed ID: 37678541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibudilast attenuates alcohol cue-elicited frontostriatal functional connectivity in alcohol use disorder.
    Burnette EM; Ray LA; Irwin MR; Grodin EN
    Alcohol Clin Exp Res; 2021 Oct; 45(10):2017-2028. PubMed ID: 34585396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.